Compositions and methods comprising the use of a Bacillus agaradhaerens inulosucrase (INUO)
US11859216B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2020 |
| Grant date | Jan 2, 2024 |
| Priority date | — |
| Expiry date | Apr 1, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y204/01009
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Bacillus agaradhaerens strain WDG185 expresses an inulosucrase that efficiently synthesizes a broad range of IOS with a GF range of GF3-GF30. The isolated and/or purified inulosucrase, recombinantly engineered variants thereof, active fragments thereof, synthetic nucleic acids encoding the inulosucrase, its variants, or its active fragments, host cells comprising the synthetic nucleic acids, and compositions comprising the inulosucrase are provided. Methods of using the compositions include the manufacture of inulooligosaccharides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.